{"url":"https://lda.senate.gov/api/v1/filings/ea790dc8-4bc8-4150-b864-e4ded6fd96a6/","filing_uuid":"ea790dc8-4bc8-4150-b864-e4ded6fd96a6","filing_type":"Q4","filing_type_display":"4th Quarter - Report","filing_year":2025,"filing_period":"fourth_quarter","filing_period_display":"4th Quarter (Oct 1 - Dec 31)","filing_document_url":"https://lda.senate.gov/filings/public/filing/ea790dc8-4bc8-4150-b864-e4ded6fd96a6/print/","filing_document_content_type":"text/html","income":null,"expenses":"470000.00","expenses_method":"A","expenses_method_display":"A","posted_by_name":"Erin Polak","dt_posted":"2026-01-20T13:59:48-05:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"1401 New York Ave NW","registrant_address_2":"Suite 701","registrant_different_address":false,"registrant_city":"Washington","registrant_state":"DC","registrant_zip":"20005","registrant":{"id":401105524,"url":"https://lda.senate.gov/api/v1/registrants/401105524/","house_registrant_id":null,"name":"GRAIL, INC. (FORMERLY GRAIL, LLC)","description":"Biotechnology Company","address_1":"1401 New York Ave","address_2":"Suite 701","address_3":null,"address_4":null,"city":"Washington","state":"DC","state_display":"District of Columbia","zip":"20005","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"ERIN POLAK","contact_telephone":"+1 202-661-7618","dt_updated":"2026-01-30T15:42:15.058344-05:00"},"client":{"id":203795,"url":"https://lda.senate.gov/api/v1/clients/203795/","client_id":12,"name":"GRAIL, INC. (FORMERLY GRAIL, LLC)","general_description":null,"client_government_entity":false,"client_self_select":true,"state":"DC","state_display":"District of Columbia","country":"US","country_display":"United States of America","ppb_state":"DC","ppb_state_display":"District of Columbia","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2021-08-24"},"lobbying_activities":[{"general_issue_code":"MMM","general_issue_code_display":"Medicare/Medicaid","description":"HR 842/S. 339- Nancy Gardner Sewell Medicare Multi-Cancer Early Detection Screening Coverage Act","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":72354,"prefix":null,"prefix_display":null,"first_name":"ERIN","nickname":null,"middle_name":null,"last_name":"POLAK","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":151172,"prefix":"ms","prefix_display":"MS.","first_name":"BARBARA","nickname":null,"middle_name":"ANNE","last_name":"MENARD","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"HR 842/S. 339- Nancy Gardner Sewell Medicare Multi-Cancer Early Detection Screening Coverage Act","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":72354,"prefix":null,"prefix_display":null,"first_name":"ERIN","nickname":null,"middle_name":null,"last_name":"POLAK","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":151172,"prefix":"ms","prefix_display":"MS.","first_name":"BARBARA","nickname":null,"middle_name":"ANNE","last_name":"MENARD","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]}